Association Between Airflow Limitation and Carotid Intima-Media Thickness in the Japanese Population

References

• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; 2020. Available from: https://goldcopd.org. Accessed August 28, 2020.
   Google Scholar
• World Health Organization. Available from: https://www.who.int/gho/mortality_burden_disease/causes_death/top_10/en/. Accessed August 28, 2020.
   Google Scholar
• World health organization. Chronic obstructive pulmonary disease (COPD). Available from: https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd). Accessed August 30, 2020.
   Google Scholar
• Japanese Respiratory Society. The JRS Guidelines for the Management of Chronic Obstructive Pulmonary Disease. 5th ed. Tokyo: Medical Review Co., Ltd; 2018.
   Google Scholar
• Chen W, Thomas J, Sadatsafavi M, FitzGerald JM. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis. Lancet Respir Med. 2015;3(8):631–639. doi:10.1016/S2213-2600(15)00241-6
   PubMed Web of Science ®Google Scholar
• Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33(5):1165–1185. doi:10.1183/09031936.00128008
   PubMed Web of Science ®Google Scholar
• Müllerova H, Agusti A, Erqou S, Mapel DW. Cardiovascular comorbidity in COPD: systematic literature review. Chest. 2013;144(4):1163–1178. doi:10.1378/chest.12-2847
   PubMed Web of Science ®Google Scholar
• Miller J, Edwards LD, Agustí A, et al. Comorbidity, systemic inflammation and outcomes in the ECLIPSE cohort. Respir Med. 2013;107(9):1376–1384. doi:10.1016/j.rmed.2013.05.001
   PubMed Web of Science ®Google Scholar
• Johnston AK, Mannino DM, Hagan GW, Davis KJ, Kiri VA. Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohort. Thorax. 2008;63(7):599–605. doi:10.1136/thx.2007.088112
   PubMed Web of Science ®Google Scholar
• Shibata Y, Inoue S, Igarashi A, et al. A lower level of forced expiratory volume in 1 second is a risk factor for all-cause and cardiovascular mortality in a Japanese population: the Takahata study. PLoS One. 2013;8(12):e83725. doi:10.1371/journal.pone.0083725
   PubMed Web of Science ®Google Scholar
• Sin DD, Wu L, Paul Man SF. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest. 2005;127(6):1952–1959. doi:10.1378/chest.127.6.1952
   PubMed Web of Science ®Google Scholar
• Lamprecht B, McBurnie MA, Vollmer WM, et al. COPD in never smokers: results from the population-based burden of obstructive lung disease study. Chest. 2011;139(4):752–763. doi:10.1378/chest.10-1253
   PubMed Web of Science ®Google Scholar
• Gudmundsson G, Margretardottir OB, Sigurdsson MI, et al. Airflow obstruction, atherosclerosis and cardiovascular risk factors in the AGES Reykjavik study. Atherosclerosis. 2016;252:122–127. doi:10.1016/j.atherosclerosis.2016.07.919
   PubMed Web of Science ®Google Scholar
• Franssen FME, Soriano JB, Roche N, et al. Lung function abnormalities in smokers with ischemic heart disease. Am J Respir Crit Care Med. 2016;194(5):568–576. doi:10.1164/rccm.201512-2480OC
   PubMed Web of Science ®Google Scholar
• Soriano JB, Rigo F, Guerrero D, et al. High prevalence of undiagnosed airflow limitation in patients with cardiovascular disease. Chest. 2010;137(2):333–340. doi:10.1378/chest.09-1264
   PubMed Web of Science ®Google Scholar
• Almagro P, Lapuente A, Pareja J, et al. Underdiagnosis and prognosis of chronic obstructive pulmonary disease after percutaneous coronary intervention: a prospective study. Int J Chron Obstruct Pulmon Dis. 2015;10:1353–1361. doi:10.2147/COPD.S84482
   PubMed Web of Science ®Google Scholar
• Onishi K, Yoshimoto D, Hagan GW, Jones PW. Prevalence of airflow limitation in outpatients with cardiovascular diseases in Japan. Int J Chron Obstruct Pulmon Dis. 2014;9:563–568. doi:10.2147/COPD.S59962
   PubMed Web of Science ®Google Scholar
• Iwamoto H, Yokoyama A, Kitahara Y, et al. Airflow limitation in smokers is associated with subclinical atherosclerosis. Am J Respir Crit Care Med. 2009;179(1):35–40. doi:10.1164/rccm.200804-560OC
   PubMed Web of Science ®Google Scholar
• Barr RG, Ahmed FS, Carr JJ, et al. Subclinical atherosclerosis, airflow obstruction and emphysema: the MESA Lung Study. Eur Respir J. 2012;39(4):846–854. doi:10.1183/09031936.00165410
   PubMed Web of Science ®Google Scholar
• Schroeder EB, Welch VL, Evans GW, Heiss G. Impaired lung function and subclinical atherosclerosis. The ARIC Study. Atherosclerosis. 2005;180(2):367–373. doi:10.1016/j.atherosclerosis.2004.12.012
   PubMed Web of Science ®Google Scholar
• Ebrahim S, Papacosta O, Whincup P, et al. Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study. Stroke. 1999;30(4):841–850. doi:10.1161/01.str.30.4.841
   PubMed Web of Science ®Google Scholar
• Sugiura T, Dohi Y, Takagi Y, et al. Close association between subclinical atherosclerosis and pulmonary function in middle-aged male smokers. J Atheroscler Thromb. 2020:14. doi:10.5551/jat.55996
   Web of Science ®Google Scholar
• Kudo K, Hata J, Matsumoto K, et al. Association of Airflow Limitation With Carotid Atherosclerosis in a Japanese Community – The Hisayama Study. Circ J. 2017;81(12):1846–1853. doi:10.1253/circj.CJ-16-1305
   PubMed Web of Science ®Google Scholar
• Lahousse L, van den Bouwhuijsen QJA, Loth DW, et al. Chronic obstructive pulmonary disease and lipid core carotid artery plaques in the elderly: the Rotterdam Study. Am J Respir Crit Care Med. 2013;187(1):58–64. doi:10.1164/rccm.201206-1046OC
   PubMed Web of Science ®Google Scholar
• Terminology and Diagnostic Criteria Committee, Japan society of ultrasonics in medicine, subcommittee for guidelines for ultrasound diagnosis of carotid artery. Standard method for ultrasound evaluation of carotid artery lesions, 2017. Available from https://www.jsum.or.jp/committee/diagnostic/pdf/jsum0515_guideline.pdf. Accessed July 5, 2020.
   Google Scholar
• Terminology and Diagnostic Criteria Committee, Japan Society of Ultrasonics in Medicine. Standard method for ultrasound evaluation of carotid artery lesions. J Med Ultrason. 2009;36(4):219–226. doi:10.1007/s10396-009-0238-y
   PubMed Web of Science ®Google Scholar
• Kokubo Y, Watanabe M, Higashiyama A, Nakao YM, Nakamura F, Miyamoto Y. Impact of Intima-Media Thickness Progression in the Common Carotid Arteries on the Risk of Incident Cardiovascular Disease in the Suita Study. J Am Heart Assoc. 2018;7(11):e007720. doi:10.1161/JAHA.117.007720
   PubMed Web of Science ®Google Scholar
• Oda M, Omori H, Onoue A, et al. Association between airflow limitation severity and arterial stiffness as determined by the brachial-ankle pulse wave velocity: a cross-sectional study. Intern Med. 2015;54(20):2569–2575. doi:10.2169/internalmedicine.54.3778
   PubMed Web of Science ®Google Scholar
• Omori H, Nagano M, Funakoshi Y, et al. Twelve-year cumulative incidence of airflow obstruction among Japanese males. Intern Med. 2011;50(15):1537–1544. doi:10.2169/internalmedicine.50.4412
   PubMed Web of Science ®Google Scholar
• Onoue A, Omori H, Katoh T, et al. Relationship of airflow limitation severity with work productivity reduction and sick leave in a Japanese working population. Int J Chron Obstruct Pulmon Dis. 2016;16(11):567–575. doi:10.2147/COPD.S99786
   Web of Science ®Google Scholar
• Omori H, Tsuji M, Sata K, et al. Correlation of C-reactive protein with disease severity in CT diagnosed emphysema. Respirology. 2009;14(4):551–558. doi:10.1111/j.1440-1843.2009.01519.x
   PubMed Web of Science ®Google Scholar
• Masuda S, Omori H, Onoue A, et al. Comorbidities according to airflow limitation severity: data from comprehensive health examination in Japan. Environ Health Prev Med. 2017;22(1):13. doi:10.1186/s12199-017-0620-0
   PubMed Web of Science ®Google Scholar
• Omori H, Kaise T, Suzuki T, Hagan G. Prevalence of airflow limitation in subjects undergoing comprehensive health examination in Japan: survey of Chronic Obstructive pulmonary disease Patients Epidemiology in Japan. Int J Chron Obstruct Pulmon Dis. 2016;22(11):873–880. doi:10.2147/COPD.S99935
   Google Scholar
• Watanabe K, Onoue A, Kubota K, et al. Association between airflow limitation severity and reduced bone mineral density in Japanese men. Int J Chron Obstruct Pulmon Dis. 2019;14:2355–2363. doi:10.2147/COPD.S213746
   PubMed Web of Science ®Google Scholar
• Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936
   PubMed Web of Science ®Google Scholar
• Japanese Respiratory Society. Reference values for spirometry in Japanese adult [Internet]. Available from: http://www.jrs.or.jp/modules/guidelines/index.php?content_id=12. Accessed September 3, 2020.
   Google Scholar
• World Health Organ Tech Rep Ser. Obesity: preventing and managing the global epidemic. Report WHO Consultation. 2000;894:1–253.
   Google Scholar
• Kiriyama H, Kaneko H, Itoh H, et al. Effect of cigarette smoking on carotid artery atherosclerosis: a community-based cohort study. Heart Vessels. 2020;35(1):22–29. doi:10.1007/s00380-019-01455-5
   PubMed Web of Science ®Google Scholar
• Sin DD, Paul Man SF. Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation. 2003;107(11):1514–1519. doi:10.1161/01.cir.0000056767.69054.b3
   PubMed Web of Science ®Google Scholar
• Cao JJ, Arnold AM, Manolio TA, et al. Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study. Circulation. 2007;116(1):32–38. doi:10.1161/CIRCULATIONAHA.106.645606
   PubMed Web of Science ®Google Scholar
• Sinden NJ, Stockley RA. Systemic inflammation and comorbidity in COPD: a result of ‘overspill’ of inflammatory mediators from the lungs? Review of the evidence. Thorax. 2010;65(10):930–936. doi:10.1136/thx.2009.130260
   PubMed Web of Science ®Google Scholar
• Agusti A, Soriano JB. COPD as a systemic disease. COPD. 2008;5(2):133–138. doi:10.1080/15412550801941349
   PubMedGoogle Scholar
• Gan WQ, Man SFP, Senthilselvan A, Sin DD. Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax. 2004;59(7):574–580. doi:10.1136/thx.2003.019588
   PubMed Web of Science ®Google Scholar
• Kaptoge S, Di Angelantonio E, Pennells L, et al. C-reactive protein, fibrinogen, and cardiovascular disease prediction. N Engl J Med. 2012;367(14):1310–1320. doi:10.1056/NEJMoa1107477
   PubMed Web of Science ®Google Scholar
• Thomsen M, Dahl M, Lange P, Vestbo J, Nordestgaard BG. Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012;186(10):982–988. doi:10.1164/rccm.201206-1113OC
   PubMed Web of Science ®Google Scholar
• Chandra D, Gupta A, Strollo PJ, et al. Airflow limitation and endothelial dysfunction. Unrelated and independent predictors of atherosclerosis. Am J Respir Crit Care Med. 2016;194(1):38–47. doi:10.1164/rccm.201510-2093OC
   PubMed Web of Science ®Google Scholar
• Agusti A, Calverley PM, Celli B, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort. Respir Res. 2010;11(1):122. doi:10.1186/1465-9921-11-122
   PubMed Web of Science ®Google Scholar
• Suzuki M, Makita H, Ito YM, Nagai K, Konno S, Nishimura M. Hokkaido COPD Cohort Study Investigators. Clinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort study. Eur Respir J. 2014;43(5):1289–1297. doi:10.1183/09031936.00110213
   PubMed Web of Science ®Google Scholar